Literature DB >> 24371228

Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.

Yujie Huang1, Caitlin Hoffman, Prajwal Rajappa, Joon-Hyung Kim, Wenhuo Hu, Jason Huse, Zhongshu Tang, Xuri Li, Babette Weksler, Jacqueline Bromberg, David C Lyden, Jeffrey P Greenfield.   

Abstract

Enhanced platelet-derived growth factor (PDGF) signaling in glioma drives its development and progression. In this study, we define a unique role for stroma-derived PDGF signaling in maintaining tumor homeostasis within the glioma microenvironment. Large numbers of PDGF receptor-α (PDGFRα)-expressing stromal cells derived from oligodendrocytes progenitor cells (OPC) were discovered at the invasive front of high-grade gliomas, in which they exhibited a unique perivascular distribution. In PDGFRα-deficient host mice, in which orthotopic Gl261 tumors displayed reduced outgrowth, we found that tumor-associated blood vessels displayed smaller lumens and normalized vascular morphology, with tumors in host animals injected with the vascular imaging agent gadolinium also being enhanced less avidly by MRI. Notably, glioma-associated OPC promoted endothelial sprouting and tubule formation, in part by abrogating the inhibitory effect that perivascular astrocytes exert on vascular endothelial conjunctions. Stromal-derived PDGF-CC was crucial for the recruitment and activation of OPC, insofar as mice genetically deficient in PDGF-CC phenocopied the glioma/vascular defects observed in PDGFRα-deficient mice. Clinically, we showed that higher levels of PDGF-CC in glioma specimens were associated with more rapid disease recurrence and poorer overall survival. Our findings define a PDGFRα/PDGF-CC signaling axis within the glioma stromal microenvironment that contributes to vascular remodeling and aberrant tumor angiogenesis in the brain. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24371228     DOI: 10.1158/0008-5472.CAN-13-1072

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.

Authors:  B R Achyut; Adarsh Shankar; A S M Iskander; Roxan Ara; Kartik Angara; Peng Zeng; Robert A Knight; Alfonso G Scicli; Ali S Arbab
Journal:  Cancer Lett       Date:  2015-09-21       Impact factor: 8.679

2.  Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma.

Authors:  Adarsh Shankar; Meenu Jain; Mei Jing Lim; Kartik Angara; Peng Zeng; Syed A Arbab; Asm Iskander; Roxan Ara; Ali S Arbab; Bhagelu R Achyut
Journal:  J Cancer Sci Ther       Date:  2016-07-15

Review 3.  PDGF/PDGFR axis in the neural systems.

Authors:  Susmita Sil; Palsamy Periyasamy; Annadurai Thangaraj; Ernest T Chivero; Shilpa Buch
Journal:  Mol Aspects Med       Date:  2018-02-06

4.  Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.

Authors:  Robert L Bowman; Florian Klemm; Leila Akkari; Stephanie M Pyonteck; Lisa Sevenich; Daniela F Quail; Surajit Dhara; Kenishana Simpson; Eric E Gardner; Christine A Iacobuzio-Donahue; Cameron W Brennan; Viviane Tabar; Philip H Gutin; Johanna A Joyce
Journal:  Cell Rep       Date:  2016-11-10       Impact factor: 9.423

5.  A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.

Authors:  Jinjin Shi; Binghua Wang; Zhaoyang Chen; Wei Liu; Jingjing Pan; Lin Hou; Zhenzhong Zhang
Journal:  Pharm Res       Date:  2016-03-16       Impact factor: 4.200

6.  Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.

Authors:  Prajwal Rajappa; William S Cobb; Emma Vartanian; Yujie Huang; Laura Daly; Caitlin Hoffman; Jane Zhang; Beiyi Shen; Rachel Yanowitch; Kunal Garg; Babacar Cisse; Sara Haddock; Jason Huse; David J Pisapia; Timothy A Chan; David C Lyden; Jacqueline F Bromberg; Jeffrey P Greenfield
Journal:  Clin Cancer Res       Date:  2016-12-30       Impact factor: 12.531

Review 7.  Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson's Disease Pathogenesis and Treatment.

Authors:  Dan Li; Le-Tian Huang; Cheng-Pu Zhang; Qiang Li; Jia-He Wang
Journal:  Front Aging Neurosci       Date:  2022-07-01       Impact factor: 5.702

8.  Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.

Authors:  David M Irvin; Robert S McNeill; Ryan E Bash; C Ryan Miller
Journal:  Brain Pathol       Date:  2016-04-13       Impact factor: 6.508

9.  Delayed rFGF21 Administration Improves Cerebrovascular Remodeling and White Matter Repair After Focal Stroke in Diabetic Mice.

Authors:  Yinghua Jiang; Jinrui Han; Yadan Li; Yinga Wu; Ning Liu; Samuel X Shi; Li Lin; Jing Yuan; Shusheng Wang; Ming-Ming Ning; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2021-09-15       Impact factor: 6.829

10.  The tweety Gene Family: From Embryo to Disease.

Authors:  Rithvik R Nalamalapu; Michelle Yue; Aaron R Stone; Samantha Murphy; Margaret S Saha
Journal:  Front Mol Neurosci       Date:  2021-06-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.